๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Studies on epidermal growth factor receptor signaling in vertebrate limb patterning

โœ Scribed by Minoru Omi; Melanie Fisher; Nita J. Maihle; Caroline N. Dealy


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
660 KB
Volume
233
Category
Article
ISSN
1058-8388

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Somatic mutations of epidermal growth fa
โœ Hisayuki Shigematsu; Adi F. Gazdar ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 540 KB

Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers have generated enormous interest, because they predict for sensitivity to TK inhibitors (TKIs). While mutational status is of great importance in determining response to TKIs, it

The tetraspanin CD9 modulates epidermal
โœ Yoko Murayama; Yasuhisa Shinomura; Kenji Oritani; Jun-Ichiro Miyagawa; Hitoshi Y ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 502 KB

## Abstract CD9 is a member of the tetraspanins, and has been shown to be involved in a variety of cellular activities such as migration, proliferation, and adhesion. In addition, it has been known that CD9 can associate with other proteins. Here we demonstrated the physical and functional associat

Characterization of epidermal growth fac
โœ Shi Nae Kim; Jung-Gyu Park; Eunhee Bae Lee; Soung Soo Kim; Young Sook Yoo ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB ๐Ÿ‘ 2 views

Lysophosphatidic acid (LPA) is a lipid metabolite that induces the activation of mitogen-activated protein kinase (MAPK) through binding to the G protein-coupled receptor in a number of cell lines and cultures. Recent studies have revealed that LPA is able to rapidly induce the phosphorylation of MA

Epidermal growth factor ligand/receptor
โœ Marco Volante; Silvia Saviozzi; Ida Rapa; Paolo Ceppi; Susanna Cappia; Raffaele ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 396 KB

## Abstract ## BACKGROUND. In recent years, molecular insights shed light on the role of the epidermal growth factor receptor (EGFR) in nonsmall cell lung cancer (NSCLC), and new therapeutic agents, such as the EGFR tyrosine kinase inhibitors, were tested successfully, with responsiveness to those